A University of Colorado professor who experienced a funding freeze firsthand this year expressed relief at the program's ...

Kenya has been picked among nine countries for the trials of the new injectable HIV prevention drug that has been rolled out ...

Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

Kenya is set to introduce a revolutionary injectable HIV prevention drug, Lenacapavir, becoming one of nine African nations ...

Popular global HIV/AIDS program PEPFAR has been spared as Congress passes a package with billions of dollars in spending cuts ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

In Kenya, American aid workers fired during the Trump administration's purge of USAID ask themselves: What comes next?

The third study, Twiga , is an ongoing five-year observational study tracking comorbidities in both HIV-positive and HIV-negative individuals aged 60 and above. It was initiated to better understand ...

Countries like Kenya are redoubling their efforts to meet ambitious global goals to eliminate pediatric HIV/AIDS. As they develop plans for continuity of care in future health crises, hearing directly ...

HIV and TB in Kenya When the immune system is weakened by the AIDS virus, people become vulnerable to many other infections. In parts of the world where both TB and AIDS are widespread, the number ...